Extended vs limited Pelvic Lymph node dissection in prostate cancer

In this video interview, Dr. Lestingi discusses the randomised phase-three trial of extended-versus-limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer.